From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
- PMID: 32854739
- PMCID: PMC7450684
- DOI: 10.1186/s12931-020-01479-w
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
Abstract
Within two decades, there have emerged three highly pathogenic and deadly human coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden and health threats caused by these coronaviruses are extremely dreadful and getting more serious as the increasing number of global infections and attributed deaths of SARS-CoV-2 and MERS-CoV. Unfortunately, specific medical countermeasures for these hCoVs remain absent. Moreover, the fast spread of misinformation about the ongoing SARS-CoV-2 pandemic uniquely places the virus alongside an annoying infodemic and causes unnecessary worldwide panic. SARS-CoV-2 shares many similarities with SARS-CoV and MERS-CoV, certainly, obvious differences exist as well. Lessons learnt from SARS-CoV and MERS-CoV, timely updated information of SARS-CoV-2 and MERS-CoV, and summarized specific knowledge of these hCoVs are extremely invaluable for effectively and efficiently contain the outbreak of SARS-CoV-2 and MERS-CoV. By gaining a deeper understanding of hCoVs and the illnesses caused by them, we can bridge knowledge gaps, provide cultural weapons for fighting and controling the spread of MERS-CoV and SARS-CoV-2, and prepare effective and robust defense lines against hCoVs that may emerge or reemerge in the future. To this end, the state-of-the-art knowledge and comparing the biological features of these lethal hCoVs and the clinical characteristics of illnesses caused by them are systematically summarized in the review.
Keywords: Biological features; Clinical characteristics; Illness; MERS-CoV; SARS-CoV; SARS-CoV-2.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.Infez Med. 2020 Jun 1;28(suppl 1):6-17. Infez Med. 2020. PMID: 32532933 Review.
-
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047. APMIS. 2020. PMID: 32363707 Review.
-
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16. OMICS. 2020. PMID: 32940573 Review.
-
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312. Biomolecules. 2020. PMID: 32933047 Free PMC article. Review.
-
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11. Am J Med Sci. 2020. PMID: 32620220 Free PMC article. Review.
Cited by
-
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26. Saudi J Biol Sci. 2021. PMID: 33654454 Free PMC article.
-
Smoking status and SARS-CoV-2 infection severity among Lebanese adults: a cross-sectional study.BMC Infect Dis. 2022 Sep 24;22(1):746. doi: 10.1186/s12879-022-07728-1. BMC Infect Dis. 2022. PMID: 36153476 Free PMC article.
-
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.Daru. 2022 Dec;30(2):379-406. doi: 10.1007/s40199-022-00446-8. Epub 2022 Sep 2. Daru. 2022. PMID: 36050585 Free PMC article. Review.
-
Wuhan to World: The COVID-19 Pandemic.Front Cell Infect Microbiol. 2021 Mar 30;11:596201. doi: 10.3389/fcimb.2021.596201. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33859951 Free PMC article. Review.
-
COVID-19 Pathology in the Lung, Kidney, Heart and Brain: The Different Roles of T-Cells, Macrophages, and Microthrombosis.Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124. Cells. 2022. PMID: 36231087 Free PMC article.
References
-
- Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W, Ahmed N. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020;24:2012–2019. - PubMed
-
- Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL, Lammens C, Loens K, Viveen M, Butler CC, et al. Lower respiratory tract infection in the community: associations between viral aetiology and illness course. Clin Microbiol Infect. 2020;S1198-743X(20)30168-3. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- 2018J01288/The Research Project of Science and Technology Department of Fujian Province, China
- 2018-1-62/The Youth Research Project of Health and Family Planning Commission of Fujian Province, China
- 2018-2-23/The Youth Research Project of Health and Family Planning Commission of Fujian Province, China
- 2018N012/Quanzhou Science and Technology Project
- XJM1802/The Research Project of Collaborative Innovation Center for Maternal and Infant Health Service Application Technology
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous